Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.

MLA

Griesinger, Andrea M., et al. “Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 8, Apr. 2024, pp. 1544–54. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-23-3156.

APA

Griesinger, A. M., Calzadilla, A. J., Grimaldo, E., Donson, A. M., Amani, V., Pierce, A. M., Steiner, J., Kargar, S., Serkova, N. J., Bertrand, K. C., Wright, K. D., Vibhakar, R., Hankinson, T., Handler, M., Lindsay, H. B., Foreman, N. K., & Dorris, K. (2024). Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 30(8), 1544–1554. https://doi.org/10.1158/1078-0432.CCR-23-3156

Chicago

Griesinger, Andrea M, Annaliese J Calzadilla, Enrique Grimaldo, Andrew M Donson, Vladimir Amani, Angela M Pierce, Jenna Steiner, et al. 2024. “Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30 (8): 1544–54. doi:10.1158/1078-0432.CCR-23-3156.